Abstract
A patient who underwent conversion surgery after atezolizumab plus bevacizumab for hepatocellular carcinoma with portal vein thrombosis and perihepatic lymph node metastases achieved a pathological complete response
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have